Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 5Unknown 4Active not recruiting 4Completed 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Plasma cell 4Lymphoid 2Tumor-Agnostic 1Thoracic 1Other hematologic neoplasm 1Dermatologic 1Breast 1

Conditions

Lymphoma, T-Cell, Cutaneous 1Lymphoma, Follicular 1

Interventions

Rituximab 702Cyclophosphamide 645Vincristine 353Doxorubicin 309Etoposide 305Cytarabine 271Filgrastim 250Prednisone 249Methotrexate 241fludarabine phosphate 231Dexamethasone 209fludarabine 184Peripheral Blood Stem Cell Transplantation 166Radiotherapy 161Granulocyte Colony-Stimulating Factor 145Lenalidomide 144Bendamustine Hydrochloride 142Bortezomib 127Melphalan 126ibrutinib 111Busulfan 111Mycophenolic Acid 108Whole-Body Irradiation 107Tacrolimus 96Cyclosporine 87Gemcitabine 82Ifosfamide 80Calcium Dobesilate 80Alemtuzumab 80Leucovorin 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Maintenance × Lymphoid × Clear all
NCT02063685 2022-06-21

Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma

Fondazione Italiana Linfomi - ETS

Phase 3 Completed
807 enrolled
Lymphoid

Lymphoma, Follicular

NCT02296398 2016-03-11

Long-term Use of Romidepsin in Patients With CTCL

Northwestern University

Completed
47 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡